Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease

Authors

• Giuseppe Verdile
• Simon Laws, Edith Cowan UniversityFollow
• D Henley
• David Ames
• Ashley Bush
• Kathryn Ellis
• Noel Faux
• Veer Bala Gupta, Edith Cowan University
• QiaoXin Li
• Colin Masters
• Kerryn Pike
• Christopher Rowe
• Cassandra Szoeke
• Kevin Taddei, Edith Cowan UniversityFollow
• Victor Villemagne
• Ralph Martins, Edith Cowan University

Document Type

Journal Article

Faculty

Faculty of Computing, Health and Science

School

School of Medical Sciences

RAS ID

14939

Comments

Verdile, G. , Laws, S. , Henley, D., Ames, D., Bush, A., Ellis, K., Faux, N., Gupta, V. B., Li, Q., Masters, C., Pike, K., Rowe, C., Szoeke, C., Taddei, K. , Villemagne, V., & Martins, R. N. (2012). Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease. Molecular Psychiatry, 2012/10/23/online. Available here

Abstract

Testosterone and gonadotropins have been associated with cognitive decline in men and the modulation of β amyloid (Aβ) metabolism. The relatively few studies that have investigated whether changes in one or a combination of these hormones influence Aβ levels have focused primarily on plasma Aβ1–40 and not on the more pathogenic Aβ1–42. Currently, no study has investigated whether these hormones are associated with an increase in brain amyloid deposition, ante mortem. Through the highly characterised Australian imaging, biomarkers and lifestyle study, we have determined the impact of these hormones on plasma Aβ levels and brain amyloid burden (Pittsburgh compound B (PiB) retention). Spearman’s rank correlation and linear regression analysis was carried out across the cohort and within subclassifications. Luteinizing hormone (LH) was the only variable shown, in the total cohort, to have a significant impact on plasma Aβ1–40 and Aβ1–42 levels (beta=0.163, P<0.001; beta=0.446, P<0.001). This held in subjective memory complainers (SMC) (Aβ1–40; beta=0.208, P=0.017; Aβ1–42; beta=0.215, P=0.017) but was absent in mild cognitive impairment (MCI) and Alzheimer’s disease (AD) groups. In SMC, increased frequency of the APOE-ε4 allele (beta=0.536, P<0.001) and increasing serum LH levels (beta=0.421, P=0.004) had a significant impact on PiB retention. Whereas in MCI, PiB retention was associated with increased APOE-ε4 allele copy number (beta=0.674, P<0.001) and decreasing calculated free testosterone (beta=−0.303, P=0.043). These findings suggest a potential progressive involvement of LH and testosterone in the early preclinical stages of AD. Furthermore, these hormones should be considered while attempting to predict AD at these earliest stages of the disease.

Access Rights

subscription content